Literature DB >> 20675611

Detection of androgen receptor mutations in circulating tumor cells: highlights of the long road to clinical qualification.

Hans Lilja, Howard I Scher.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2010        PMID： 20675611     DOI： 10.1373/clinchem.2010.150896

Source DB:  PubMed          Journal:  Clin Chem        ISSN： 0009-9147            Impact factor:   8.327


× No keyword cloud information.
  3 in total

Review 1.  Harnessing a Different Dependency: How to Identify and Target Androgen Receptor-Positive Versus Quadruple-Negative Breast Cancer.

Authors:  Jessica L Christenson; Jane B Trepel; Haythem Y Ali; Sunmin Lee; Joel R Eisner; Edwina S Baskin-Bey; Anthony D Elias; Jennifer K Richer
Journal:  Horm Cancer       Date:  2018-01-16       Impact factor: 3.869

2.  Detection of EpCAM-Negative and Cytokeratin-Negative Circulating Tumor Cells in Peripheral Blood.

Authors:  Stephen D Mikolajczyk; Lisa S Millar; Pavel Tsinberg; Stephen M Coutts; Maryam Zomorrodi; Tam Pham; Farideh Z Bischoff; Tony J Pircher
Journal:  J Oncol       Date:  2011-04-19       Impact factor: 4.375

3.  Isolation of Circulating Tumor Cells from Multiple Epithelial Cancers with ApoStream(®) for Detecting (or Monitoring) the Expression of Folate Receptor Alpha.

Authors:  Daniel J O'Shannessy; Darren W Davis; Kenna Anderes; Elizabeth B Somers
Journal:  Biomark Insights       Date:  2016-02-01
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.